AM
Aurélie Mahalatchimy
2
Documents
Identifiants chercheurs
- aurelie-mahalatchimy
- IdRef : 172268745
- 0000-0002-4365-2143
Présentation
**Aurélie Mahalatchimy** is an academic lawyer (PhD in law from the University of Toulouse, France). She is permanent Researcher at the French National Centre for Scientific Research (CNRS, chargée de recherche), Aix Marseille University, Toulon University, Pau & Pays AdourUniversity, International, Comparative and European laws (DICE- CERIC) research lab, Aix-en-Provence, France. She is also Associated researcher to the Centre for Global Health Policy, School of Global Studies, University of Sussex, UK.
Aurélie’smain research interest is International, European and Comparative law of biomedical innovations, especially the uses of human genes, cells and tissues for therapeutic (advanced therapy medicinal products), scientific, commercial and industrial purposes.
She has been involved in various International, European, French and UK research projects. She published 52 articles, including 23 in peer-reviewed journals, co-coordinated a special issue of the French review Quaderni on Human as therapeutics, and presented 50 communications, including 13 as invited speaker.
Publications
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
|
Ethical and legal frameworks for embryonic stem-cell based research in France and in Europe: a challenge for biotechnologyCUPL. Biotechnology Medicine and Law, 2018, 978-7-5620-8420-4
Chapitre d'ouvrage
halshs-01938427v1
|
|
In need for a modern Daedalus? The challenging regulatory path for marketing gene therapy medicinal products in China and EuropeQ. Yanping, A.-M. Duguet. Biotechnology Medicine and Law, China University of Political Science and Law Press, 2018, 978-7-5620-8420-4
Chapitre d'ouvrage
halshs-01938345v1
|